Donepezil in Early Dementia Associated with Parkinson's Disease: Multicentre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated with Parkinson's Disease

Trial Profile

Donepezil in Early Dementia Associated with Parkinson's Disease: Multicentre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated with Parkinson's Disease

Discontinued
Phase of Trial: Phase III

Latest Information Update: 27 Sep 2017

At a glance

  • Drugs Donepezil (Primary)
  • Indications Dementia; Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms MUSTARDD-PD
  • Most Recent Events

    • 05 Apr 2017 Status changed to discontinued.
    • 01 Aug 2014 Status changed from suspended to completed as reported by United Kingdom Clinical Research Network record.
    • 19 Jun 2014 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top